However, bioavailability through topical application remains limited compared to injectable delivery
Here is what researchers most often study, all in animal or cell models: Cytoprotection: Much of the early work looked at how the peptide affects the stomach and gut lining in rodents
Nangole, F
Building your GHK-CU protocol Theory means nothing without implementation
Within a couple of minutes, its completely dissolved and the GHK-Cu is already entering your bloodstream where it can travel to tissues throughout your body
While GHK-Cu is generally well-tolerated in topical research, certain contraindications or precautions should be considered, especially for systemic research or in specific populations: Systemic Research: For systemic applications, GHK-Cu is generally not recommended for subjects who are pregnant, breastfeeding, have active cancer, or suffer from Wilsons disease (a condition involving copper accumulation)